Markets:

Overview

News

Currencies

International

Treasuries

Belite Bio, Inc - American Depositary Shares (NQ:BLTE)

155.96 +1.11 (+0.71%)

Streaming Delayed Price Updated: 10:17 AM EDT, May 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Belite Bio, Inc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday ↗

June 26, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Analyst Expectations for Belite Bio's Future ↗

June 20, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 16, 2023

Friday's session saw 32 companies set new 52-week lows.

Via Benzinga

Top 5 Health Care Stocks That Are Set To Fly In Q2 ↗

June 09, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Why Shares of Belite Bio Are Slumping Wednesday ↗

May 31, 2023

The biopharmaceutical company announced a stock sale that's not great news to current investors.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 31, 2023

Via Benzinga

Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 31, 2023

Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of...

Via Benzinga

Nasdaq Down 100 Points; Advance Auto Parts Earnings Miss Views ↗

May 31, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.82% to 32,773.27 while the NASDAQ fell 0.86% to 12,905.49. The...

Via Benzinga

Dow Tumbles Over 200 Points; Chicago PMI Drops In May ↗

May 31, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.68% to 32,817.80 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 31, 2023

Via Benzinga

Why LL Flooring Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket ↗

May 31, 2023

Gainers VIQ Solutions Inc. (NASDAQ: VQS) shares rose 66.8% to $0.3887 in pre-market trading.

Via Benzinga

HP, Ambarella, Sportsmans Warehouse And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

May 31, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American Depositary Shares and Warrants

May 30, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio Announces Proposed Underwritten Public Offering of American Depositary Shares and Warrants

May 30, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results

May 10, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results

May 10, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Host Key Opinion Leader Webinar Discussing Progression of Childhood-onset STGD1 and Relevance of the Tinlarebant 18-month Phase 2 Data

May 04, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio Presented 18-Month Interim Data from a 24-Month Phase 2 Study of Tinlarebant in Adolescent Stargardt Disease at the 2023 ARVO Meeting

April 25, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Host Key Opinion Leader Webinar on RBP4 Antagonist Tinlarebant in Late-Stage Development for Stargardt Disease 1

April 11, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results

March 31, 2023

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results

March 31, 2023

From Belite Bio, Inc

Via GlobeNewswire

3 Breakout Growth Stocks to Buy for the Long Haul ↗

January 09, 2023

These three have had big-time share gains backed up by breakthrough science.

Via The Motley Fool

2 Stocks Up 165% and 209% in 2022 That Could Keep Soaring in 2023 ↗

December 08, 2022

Find out how these stock rockets could continue their ascent.

Via The Motley Fool

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday ↗

November 21, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Belite Bio Finalizes Phase 3 Clinical Trial Plans for Advanced Dry AMD Treatment with Tinlarebant (LBS-008)

November 18, 2022

From Belite Bio, Inc

Via GlobeNewswire

Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data

October 20, 2022

From Belite Bio, Inc

Via GlobeNewswire

3 Soaring Biotech Stocks That Could Climb Much Higher ↗

October 20, 2022

These drugmakers have bucked the overall market's downward trend this year and expectations are still high.

Via The Motley Fool

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.